시장보고서
상품코드
1828802

세계의 카나비노이드 기반 신약 개발 및 연구 시장 분석 및 예측(-2034년) : 유형, 제품, 서비스, 기술, 용도, 제형, 최종 사용자, 단계, 방식, 기능

Cannabinoid Based Drug Discovery And Development Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, Form, End User, Stage, Mode, Functionality

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 408 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

카나비노이드 기반 신약 개발 및 연구 시장은 2024년 17억 6,000만 달러에서 2034년에는 22억 8,000만 달러로 확대되어 약 2.6%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예측되고 있습니다. 카나비노이드 기반 신약 개발 및 연구 시장에는 다양한 병리학을 표적으로 한 카나비노이드 유래의 의약품의 연구개발이 포함됩니다. 이 시장은 생명 공학의 진보를 활용하고 통증 관리, 신경 질환, 종양학에 중점을두고 대마초 화합물의 치료 가능성을 탐구합니다. 엄격한 의료 기준을 충족하기 위한 임상시험과 안전성 평가가 중시되는 가운데, 규제 시프트와 대마초 기반 치료에 대한 수용 확대가 기술 혁신을 추진하고 있습니다.

카나비노이드 기반 신약 개발 및 연구 시장은 치료에 대한 응용 연구 증가에 힘입어 강력한 성장을 이루고 있습니다. 통증 관리 및 신경 질환에 대한 카나비노이드 기반 치료제에 대한 관심 증가로 의약품 분야가 최전선에 있습니다. 이 부문에서 합성 카나비노이드는 제어된 조성과 예측 가능한 효과로 최상의 성과를 올리고 있습니다. 천연 카나비노이드는 식물 유래 화합물에 대한 선호도 증가를 반영하여 두 번째로 높은 성과를 올리고 있습니다. 연구개발서비스 분야는 또한 유망한 성장을 보여주며, 계약연구기관(CRO)이 카나비노이드 연구의 추진에 있어 매우 중요한 역할을 하고 있습니다. 종합적인 안전과 효능 데이터의 필요성으로 전임상 조사 서비스가 주도하고 있습니다. 임상시험 서비스는 카나비노이드 기반 치료에 대한 규제 당국의 승인 증가에 힘입어 두 번째로 역동적인 하위 부문입니다. 나노기술 및 경피 패치와 같은 혁신적인 전달 시스템에 대한 투자는 시장 잠재력을 더욱 높여 이해관계자에게 유리한 궤도를 보여줍니다.

시장 세분화
유형 합성 카나비노이드, 천연 카나비노이드
제품 칸나비디올(CBD), 테트라하이드로칸나비놀(THC), 칸나비게롤(CBG), 칸나비놀(CBN), 칸나비크로멘(CBC)
서비스 전임상 연구, 임상 시험, 규제 컨설팅, 약물 제형 개발
기술 고성능 액체 크로마토그래피(HPLC), 가스 크로마토그래피(GC), 질량 분석법(MS), 핵자기 공명(NMR)
용도 통증 관리, 신경계 질환, 종양학, 정신 질환
제형 정제, 캡슐, 오일, 크림, 흡입기
최종 사용자 제약 회사, 연구 기관, 계약연구기관
단계 신약 발굴, 전임상, Phase I , Phase II, Phase III
방식 자체 수행, 외부 위탁
기능 진통, 항염증, 항경련, 신경보호

시장 현황

카나비노이드 기반 신약 개발 및 연구 시장은 시장 점유율, 가격 전략, 신제품 출시에 역동적인 변화를 볼 수 있습니다. 각 회사는 혁신적인 제제와 전략적 파트너십을 활용하여 시장에서의 지위를 높이고 있습니다. 가격 전략은 합리적인 가격과 최첨단 R&D 비용의 균형을 맞추는 필요성을 반영하여 경쟁이 치열해지고 있습니다. 신흥 시장에서는 규제상황이 더욱 유리해지고, 카나비노이드 기반 치료제의 유통이 확대됨에 따라 제품의 상시가 급증하고 있습니다. 이러한 환경은 성장과 혁신에 적합한 상황을 키우고 있습니다. 시장 경쟁은 치열하며 주요 기업들은 첨단 연구 능력과 다양한 제품 포트폴리오를 통해 패권을 다투고 있습니다. 규제 당국의 영향도 중요한 역할을 하고 있으며, 북미와 유럽에서는 엄격한 지침이 제품 승인과 시장 진입을 위한 높은 기준을 정하고 있습니다. 경쟁업체에 대한 벤치마킹은 임상시험과 특허취득에 대한 투자가 증가하는 경향이 있음을 드러내고 있습니다. 시장은 급속한 기술 진보를 특징으로 하며 경쟁 우위를 유지하기 위해 기업은 기술 혁신과 규제 준수에 있어 우위를 차지하는 것이 필수적입니다.

주요 동향 및 성장 촉진요인 :

카나비노이드 기반 신약 개발 및 연구 시장은 규제 상황의 진화와 카나비노이드 기반 치료제의 수용 확대로 강력한 성장을 이루고 있습니다. 주요 동향은 만성 통증 관리에서 신경 질환에 이르기까지 광범위한 병리학에 대한 카나비노이드의 임상시험 증가를 포함합니다. 제약 업계에서는 창약 개발 프로세스의 가속을 목적으로 한 전략적 파트너십과 공동 연구가 급증하고 있습니다. 중요한 추진력은 카나비노이드의 치료 가능성에 대한 인식 증가이며, 연구 개발에 대한 투자에 박차를 가하고 있습니다. 이는 생명공학과 유전체학의 진보로 더욱 강화되어 카나비노이드 기반 약물의 보다 정확한 표적화 및 제형화를 가능하게 합니다. 다양한 지역에서의 합법화 노력으로 시장 접근이 확대되고 혁신적인 치료에 대한 수요가 증가하고 있습니다. 또한 만성 질환 증가와 노화로 인해 새로운 치료 옵션에 대한 필요성이 증가하고 있으며, 카나비노이드는 유망한 대체 약물로 자리 잡고 있습니다. 복잡한 규제 환경을 극복하고 효과적이고 안전하며 컴플라이언스를 준수하는 카나비노이드 기반 치료제를 제공할 수 있는 기업에는 기회가 넘쳐납니다. 시장이 성숙함에 따라 특히 건강 관리 인프라가 정비되고 있는 신흥 시장에서 큰 성장 가능성이 있습니다.

성장 억제요인 및 도전 :

카나비노이드 기반 신약 개발 및 연구 시장은 몇 가지 뚜렷한 억제요인과 문제에 직면하고 있습니다. 국가에 따라 법적 틀이 다르기 때문에 연구개발 노력이 복잡해지고 규제상의 장애물은 여전히 큰 장벽이 되고 있습니다. 이러한 불일치는 의약품 승인 프로세스를 지연시키고 컴플라이언스 비용을 증가시킵니다. 게다가 대마 유래 제품을 둘러싼 스티그마(낙인)는 뿌리 깊고 사회적인식과 투자자의 신뢰에 영향을 미치고 있습니다. 이 스티그마는 잠재적인 파트너십과 자금 조달 기회를 방해할 수 있습니다. 게다가 인체 내에서의 카나비노이드 상호작용은 복잡하기 때문에 첨단 조사 기법이 필요하며 시간과 자원에 상당한 투자가 필요합니다. 지적재산의 문제도 과제이며 기존 특허가 밀집되어 법적 분쟁으로 발전하여 혁신을 방해할 수 있습니다. 마지막으로, 시장은 공급망의 제약, 특히 고품질 원재료의 조달을 걱정하며, 이는 생산 일정과 비용 구조에 영향을 미칠 수 있습니다. 이러한 과제는 전반적으로 시장 성장과 널리 받아 들여질 가능성을 방해합니다.

주요 기업

GW Pharmaceuticals, Corbus Pharmaceuticals, Zynerba Pharmaceuticals, Cara Therapeutics, InMed Pharmaceuticals, Tetra Bio-Pharma, Kalytera Therapeutics, Axim Biotechnologies, Emerald Health Pharmaceuticals, Vitality Biopharma, RespireRex Sciences, Ananda Scientific, Cardiol Therapeutics, Skylight Health Group, Medipharm Labs, Avicanna, PharmaCielo, The Valens Company, Lexaria Bioscience

목차

제1장 카나비노이드 기반 신약 개발 및 연구 시장 개요

  • 조사 목적
  • 카나비노이드 기반 신약 개발 및 연구 시장 정의 및 조사 범위
  • 보고서 제한 사항
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 카나비노이드 기반 신약 개발 및 연구 시장 전망

  • 카나비노이드 기반 신약 개발 및 연구 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 카나비노이드 기반 신약 개발 및 연구 시장 개척 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 카나비노이드 기반 신약 개발 및 연구 시장 규모

  • 카나비노이드 기반 신약 개발 및 연구 시장 규모 : 금액별
  • 카나비노이드 기반 신약 개발 및 연구 시장 규모 : 수량 기준

제7장 카나비노이드 기반 신약 개발 및 연구 시장 : 유형별

  • 시장 개요
  • 합성 카나비노이드
  • 천연 카나비노이드
  • 기타

제8장 카나비노이드 기반 신약 개발 및 연구 시장 : 제품별

  • 시장 개요
  • 칸나비디올(CBD)
  • 테트라하이드로칸나비놀(THC)
  • 칸나비게롤(CBG)
  • 칸나비놀(CBN)
  • 칸나비크로멘(CBC)
  • 기타

제9장 카나비노이드 기반 신약 개발 및 연구 시장 : 서비스별

  • 시장 개요
  • 전임상 연구
  • 임상시험
  • 규제 컨설팅
  • 약물 제형 개발
  • 기타

제10장 카나비노이드 기반 신약 개발 및 연구 시장 : 기술별

  • 시장 개요
  • 고성능ㅇ 액체 크로마토그래피(HPLC)
  • 가스 크로마토그래피(GC)
  • 질량 분석법(MS)
  • 핵자기 공명(NMR)
  • 기타

제11장 카나비노이드 기반 신약 개발 및 연구 시장 : 용도별

  • 시장 개요
  • 통증 관리
  • 신경계 질환
  • 종양학
  • 정신질환
  • 기타

제12장 카나비노이드 기반 신약 개발 및 연구 시장 : 형태별

  • 시장 개요
  • 정제
  • 캡슐
  • 오일
  • 크림
  • 흡입기
  • 기타

제13장 카나비노이드 기반 신약 개발 및 연구 시장 : 최종 사용자별

  • 시장 개요
  • 제약 회사
  • 연구 기관
  • 계약연구기관
  • 기타

제14장 카나비노이드 기반 신약 개발 및 연구 시장 : 단계별

  • 시장 개요
  • 신약 발굴
  • 전임상
  • Phase I
  • Phase II
  • Phase III
  • 기타

제15장 카나비노이드 기반 신약 개발 및 연구 시장 : 모드별

  • 시장 개요
  • 자체 수행
  • 외부 위탁
  • 기타

제16장 카나비노이드 기반 신약 개발 및 연구 시장 : 기능별

  • 시장 개요
  • 진통
  • 항염증
  • 항경련
  • 신경보호
  • 기타

제17장 카나비노이드 기반 신약 개발 및 연구 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제18장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제19장 기업 프로파일

  • Schneider Electric
  • Eaton
  • ABB
  • Siemens
  • Legrand
  • Mitsubishi Electric
  • Larsen & Toubro
  • Fuji Electric
  • CHINT Group
  • Hager Group
  • Hyundai Electric
  • Toshiba
  • Hitachi
  • Hyosung
  • NHP Electrical Engineering Products
  • Crompton Greaves
  • NOARK Electric
  • Socomec
  • Terasaki Electric
  • Efacec
KTH

Cannabinoid Based Drug Discovery And Development Market is anticipated to expand from $1.76 billion in 2024 to $2.28 billion by 2034, growing at a CAGR of approximately 2.6%. The Cannabinoid Based Drug Discovery And Development Market encompasses the research and creation of pharmaceuticals derived from cannabinoids, targeting various medical conditions. This market leverages advancements in biotechnology to explore therapeutic potentials of cannabis compounds, focusing on pain management, neurological disorders, and oncology. Regulatory shifts and increasing acceptance of cannabis-based treatments propel innovation, with a strong emphasis on clinical trials and safety assessments to meet stringent medical standards.

The Cannabinoid Based Drug Discovery And Development Market is experiencing robust growth, propelled by increased research into therapeutic applications. The pharmaceuticals segment is at the forefront, driven by rising interest in cannabinoid-based therapeutics for pain management and neurological disorders. Within this segment, synthetic cannabinoids are the top performers due to their controlled composition and predictable effects. Natural cannabinoids follow as the second highest performing sub-segment, reflecting a growing preference for plant-derived compounds. The research and development services segment also shows promising growth, with contract research organizations (CROs) playing a pivotal role in advancing cannabinoid research. Preclinical research services are leading, driven by the need for comprehensive safety and efficacy data. Clinical trials services are the second most dynamic sub-segment, supported by increased regulatory approvals for cannabinoid-based treatments. Investment in innovative delivery systems, such as nanotechnology and transdermal patches, further enhances market potential, indicating a lucrative trajectory for stakeholders.

Market Segmentation
TypeSynthetic Cannabinoids, Natural Cannabinoids
ProductCannabidiol (CBD), Tetrahydrocannabinol (THC), Cannabigerol (CBG), Cannabinol (CBN), Cannabichromene (CBC)
ServicesPreclinical Research, Clinical Trials, Regulatory Consulting, Drug Formulation
TechnologyHigh-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Nuclear Magnetic Resonance (NMR)
ApplicationPain Management, Neurological Disorders, Oncology, Psychiatric Disorders
FormTablets, Capsules, Oils, Creams, Inhalers
End UserPharmaceutical Companies, Research Institutes, Contract Research Organizations
StageDiscovery, Preclinical, Phase I, Phase II, Phase III
ModeIn-House, Outsourced
FunctionalityAnalgesic, Anti-inflammatory, Anti-convulsant, Neuroprotective

Market Snapshot:

The Cannabinoid Based Drug Discovery and Development Market is witnessing dynamic shifts in market share, pricing strategies, and new product launches. Companies are leveraging innovative formulations and strategic partnerships to enhance their market positions. Pricing strategies are increasingly competitive, reflecting the need to balance affordability with cutting-edge research and development costs. Emerging markets are seeing a surge in product launches as regulatory landscapes become more favorable, allowing for a wider distribution of cannabinoid-based therapeutics. This environment fosters a landscape ripe for growth and innovation. Competition in the market is intense, with key players vying for dominance through advanced research capabilities and diversified product portfolios. Regulatory influences play a critical role, with stringent guidelines in North America and Europe setting high standards for product approval and market entry. Benchmarking against competitors reveals a trend towards increased investment in clinical trials and patent acquisitions. The market is characterized by rapid technological advancements, making it imperative for companies to stay ahead in innovation and regulatory compliance to maintain competitive advantage.

Geographical Overview:

The cannabinoid-based drug discovery and development market is witnessing notable growth across various regions, each presenting unique opportunities. North America leads the charge, driven by progressive legalization policies and substantial investments in research and development. The region's robust pharmaceutical infrastructure and consumer acceptance further accelerate market expansion. Europe follows with strong regulatory support and a growing focus on cannabinoid therapeutics for chronic conditions. The region's commitment to innovation and clinical trials enhances its market potential. In the Asia Pacific, the market is burgeoning, propelled by increasing awareness and investments in cannabinoid research. Countries like Australia and China are emerging as key players, leveraging scientific advancements and supportive regulations. Latin America and the Middle East & Africa are nascent markets with promising prospects. In Latin America, countries like Colombia are capitalizing on favorable climates for cannabis cultivation. Meanwhile, the Middle East & Africa are gradually recognizing the medicinal potential of cannabinoids, driving future growth.

Key Trends and Drivers:

The Cannabinoid Based Drug Discovery And Development Market is experiencing robust growth due to evolving regulatory landscapes and increasing acceptance of cannabinoid-based therapeutics. Key trends include the rise in clinical trials exploring cannabinoids for a wide range of medical conditions, from chronic pain management to neurological disorders. The pharmaceutical industry is witnessing a surge in strategic partnerships and collaborations aimed at accelerating drug discovery and development processes. A significant driver is the growing awareness of cannabinoids' therapeutic potential, which is spurring investment in research and development. This is further bolstered by advancements in biotechnology and genomics, enabling more precise targeting and formulation of cannabinoid-based drugs. Legalization efforts across various regions are expanding market access and fueling demand for innovative treatments. Additionally, the increasing prevalence of chronic diseases and an aging population are intensifying the need for novel therapeutic options, positioning cannabinoids as a promising alternative. Opportunities abound for companies that can navigate the complex regulatory environment and deliver effective, safe, and compliant cannabinoid-based therapies. As the market matures, there is potential for substantial growth, particularly in emerging markets with evolving healthcare infrastructures.

Restraints and Challenges:

The cannabinoid-based drug discovery and development market faces several notable restraints and challenges. Regulatory hurdles remain a significant barrier, as varying legal frameworks across countries complicate research and development efforts. This inconsistency can delay drug approval processes and increase compliance costs. Additionally, the stigma surrounding cannabis-derived products persists, affecting public perception and investor confidence. This stigma can deter potential partnerships and funding opportunities. Furthermore, the complexity of cannabinoid interactions within the human body requires sophisticated research methodologies, demanding substantial investment in time and resources. Intellectual property issues also pose challenges, as the dense landscape of existing patents can lead to legal disputes and hinder innovation. Lastly, the market grapples with supply chain constraints, particularly in sourcing high-quality raw materials, which can impact production timelines and cost structures. These challenges collectively impede the market's growth and potential for broader acceptance.

Key Players:

GW Pharmaceuticals, Corbus Pharmaceuticals, Zynerba Pharmaceuticals, Cara Therapeutics, InMed Pharmaceuticals, Tetra Bio-Pharma, Kalytera Therapeutics, Axim Biotechnologies, Emerald Health Pharmaceuticals, Vitality Biopharma, RespireRx Pharmaceuticals, CannbioRx Life Sciences, Ananda Scientific, Cardiol Therapeutics, Skylight Health Group, Medipharm Labs, Avicanna, PharmaCielo, The Valens Company, Lexaria Bioscience

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Cannabinoid Based Drug Discovery And Development Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Cannabinoid Based Drug Discovery And Development Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by Form
  • 2.9 Key Highlights of the Market, by End User
  • 2.10 Key Highlights of the Market, by Stage
  • 2.11 Key Highlights of the Market, by Mode
  • 2.12 Key Highlights of the Market, by Functionality
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by Form
  • 3.8 Market Attractiveness Analysis, by End User
  • 3.9 Market Attractiveness Analysis, by Stage
  • 3.10 Market Attractiveness Analysis, by Mode
  • 3.11 Market Attractiveness Analysis, by Functionality
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: Cannabinoid Based Drug Discovery And Development Market Outlook

  • 4.1 Cannabinoid Based Drug Discovery And Development Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Cannabinoid Based Drug Discovery And Development Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Cannabinoid Based Drug Discovery And Development Market Size

  • 6.1 Cannabinoid Based Drug Discovery And Development Market Size, by Value
  • 6.2 Cannabinoid Based Drug Discovery And Development Market Size, by Volume

7: Cannabinoid Based Drug Discovery And Development Market, by Type

  • 7.1 Market Overview
  • 7.2 Synthetic Cannabinoids
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Natural Cannabinoids
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: Cannabinoid Based Drug Discovery And Development Market, by Product

  • 8.1 Market Overview
  • 8.2 Cannabidiol (CBD)
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Tetrahydrocannabinol (THC)
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Cannabigerol (CBG)
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Cannabinol (CBN)
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Cannabichromene (CBC)
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Others
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region

9: Cannabinoid Based Drug Discovery And Development Market, by Services

  • 9.1 Market Overview
  • 9.2 Preclinical Research
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Clinical Trials
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Regulatory Consulting
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Drug Formulation
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Others
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region

10: Cannabinoid Based Drug Discovery And Development Market, by Technology

  • 10.1 Market Overview
  • 10.2 High-Performance Liquid Chromatography (HPLC)
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Gas Chromatography (GC)
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Mass Spectrometry (MS)
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Nuclear Magnetic Resonance (NMR)
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Others
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region

11: Cannabinoid Based Drug Discovery And Development Market, by Application

  • 11.1 Market Overview
  • 11.2 Pain Management
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Neurological Disorders
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Oncology
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Psychiatric Disorders
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: Cannabinoid Based Drug Discovery And Development Market, by Form

  • 12.1 Market Overview
  • 12.2 Tablets
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Capsules
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Oils
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Creams
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Inhalers
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Cannabinoid Based Drug Discovery And Development Market, by End User

  • 13.1 Market Overview
  • 13.2 Pharmaceutical Companies
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Research Institutes
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Contract Research Organizations
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Cannabinoid Based Drug Discovery And Development Market, by Stage

  • 14.1 Market Overview
  • 14.2 Discovery
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Preclinical
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Phase I
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Phase II
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Phase III
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Others
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region

15: Cannabinoid Based Drug Discovery And Development Market, by Mode

  • 15.1 Market Overview
  • 15.2 In-House
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Outsourced
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Cannabinoid Based Drug Discovery And Development Market, by Functionality

  • 16.1 Market Overview
  • 16.2 Analgesic
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Anti-inflammatory
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Anti-convulsant
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region
  • 16.5 Neuroprotective
    • 16.5.1 Key Market Trends & Opportunity Analysis
    • 16.5.2 Market Size and Forecast, by Region
  • 16.6 Others
    • 16.6.1 Key Market Trends & Opportunity Analysis
    • 16.6.2 Market Size and Forecast, by Region

17: Cannabinoid Based Drug Discovery And Development Market, by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Services
    • 17.2.5 North America Market Size and Forecast, by Technology
    • 17.2.6 North America Market Size and Forecast, by Application
    • 17.2.7 North America Market Size and Forecast, by Form
    • 17.2.8 North America Market Size and Forecast, by End User
    • 17.2.9 North America Market Size and Forecast, by Stage
    • 17.2.10 North America Market Size and Forecast, by Mode
    • 17.2.11 North America Market Size and Forecast, by Functionality
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Services
      • 17.2.9.4 United States Market Size and Forecast, by Technology
      • 17.2.9.5 United States Market Size and Forecast, by Application
      • 17.2.9.6 United States Market Size and Forecast, by Form
      • 17.2.9.7 United States Market Size and Forecast, by End User
      • 17.2.9.8 United States Market Size and Forecast, by Stage
      • 17.2.9.9 United States Market Size and Forecast, by Mode
      • 17.2.9.10 United States Market Size and Forecast, by Functionality
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Services
      • 17.2.10.4 Canada Market Size and Forecast, by Technology
      • 17.2.10.5 Canada Market Size and Forecast, by Application
      • 17.2.10.6 Canada Market Size and Forecast, by Form
      • 17.2.10.7 Canada Market Size and Forecast, by End User
      • 17.2.10.8 Canada Market Size and Forecast, by Stage
      • 17.2.10.9 Canada Market Size and Forecast, by Mode
      • 17.2.10.10 Canada Market Size and Forecast, by Functionality
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Services
    • 17.3.5 Europe Market Size and Forecast, by Technology
    • 17.3.6 Europe Market Size and Forecast, by Application
    • 17.3.7 Europe Market Size and Forecast, by Form
    • 17.3.8 Europe Market Size and Forecast, by End User
    • 17.3.9 Europe Market Size and Forecast, by Stage
    • 17.3.10 Europe Market Size and Forecast, by Mode
    • 17.3.11 Europe Market Size and Forecast, by Functionality
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Form
      • 17.3.9.7 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Mode
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Functionality
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Services
      • 17.3.10.4 Germany Market Size and Forecast, by Technology
      • 17.3.10.5 Germany Market Size and Forecast, by Application
      • 17.3.10.6 Germany Market Size and Forecast, by Form
      • 17.3.10.7 Germany Market Size and Forecast, by End User
      • 17.3.10.8 Germany Market Size and Forecast, by Stage
      • 17.3.10.9 Germany Market Size and Forecast, by Mode
      • 17.3.10.10 Germany Market Size and Forecast, by Functionality
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Services
      • 17.3.11.4 France Market Size and Forecast, by Technology
      • 17.3.11.5 France Market Size and Forecast, by Application
      • 17.3.11.6 France Market Size and Forecast, by Form
      • 17.3.11.7 France Market Size and Forecast, by End User
      • 17.3.11.8 France Market Size and Forecast, by Stage
      • 17.3.11.9 France Market Size and Forecast, by Mode
      • 17.3.11.10 France Market Size and Forecast, by Functionality
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Services
      • 17.3.12.4 Spain Market Size and Forecast, by Technology
      • 17.3.12.5 Spain Market Size and Forecast, by Application
      • 17.3.12.6 Spain Market Size and Forecast, by Form
      • 17.3.12.7 Spain Market Size and Forecast, by End User
      • 17.3.12.8 Spain Market Size and Forecast, by Stage
      • 17.3.12.9 Spain Market Size and Forecast, by Mode
      • 17.3.12.10 Spain Market Size and Forecast, by Functionality
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Services
      • 17.3.13.4 Italy Market Size and Forecast, by Technology
      • 17.3.13.5 Italy Market Size and Forecast, by Application
      • 17.3.13.6 Italy Market Size and Forecast, by Form
      • 17.3.13.7 Italy Market Size and Forecast, by End User
      • 17.3.13.8 Italy Market Size and Forecast, by Stage
      • 17.3.13.9 Italy Market Size and Forecast, by Mode
      • 17.3.13.10 Italy Market Size and Forecast, by Functionality
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Services
      • 17.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.5 Netherlands Market Size and Forecast, by Application
      • 17.3.14.6 Netherlands Market Size and Forecast, by Form
      • 17.3.14.7 Netherlands Market Size and Forecast, by End User
      • 17.3.14.8 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.9 Netherlands Market Size and Forecast, by Mode
      • 17.3.14.10 Netherlands Market Size and Forecast, by Functionality
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Services
      • 17.3.15.4 Sweden Market Size and Forecast, by Technology
      • 17.3.15.5 Sweden Market Size and Forecast, by Application
      • 17.3.15.6 Sweden Market Size and Forecast, by Form
      • 17.3.15.7 Sweden Market Size and Forecast, by End User
      • 17.3.15.8 Sweden Market Size and Forecast, by Stage
      • 17.3.15.9 Sweden Market Size and Forecast, by Mode
      • 17.3.15.10 Sweden Market Size and Forecast, by Functionality
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Services
      • 17.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.5 Switzerland Market Size and Forecast, by Application
      • 17.3.16.6 Switzerland Market Size and Forecast, by Form
      • 17.3.16.7 Switzerland Market Size and Forecast, by End User
      • 17.3.16.8 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.9 Switzerland Market Size and Forecast, by Mode
      • 17.3.16.10 Switzerland Market Size and Forecast, by Functionality
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Services
      • 17.3.17.4 Denmark Market Size and Forecast, by Technology
      • 17.3.17.5 Denmark Market Size and Forecast, by Application
      • 17.3.17.6 Denmark Market Size and Forecast, by Form
      • 17.3.17.7 Denmark Market Size and Forecast, by End User
      • 17.3.17.8 Denmark Market Size and Forecast, by Stage
      • 17.3.17.9 Denmark Market Size and Forecast, by Mode
      • 17.3.17.10 Denmark Market Size and Forecast, by Functionality
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Services
      • 17.3.18.4 Finland Market Size and Forecast, by Technology
      • 17.3.18.5 Finland Market Size and Forecast, by Application
      • 17.3.18.6 Finland Market Size and Forecast, by Form
      • 17.3.18.7 Finland Market Size and Forecast, by End User
      • 17.3.18.8 Finland Market Size and Forecast, by Stage
      • 17.3.18.9 Finland Market Size and Forecast, by Mode
      • 17.3.18.10 Finland Market Size and Forecast, by Functionality
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Services
      • 17.3.19.4 Russia Market Size and Forecast, by Technology
      • 17.3.19.5 Russia Market Size and Forecast, by Application
      • 17.3.19.6 Russia Market Size and Forecast, by Form
      • 17.3.19.7 Russia Market Size and Forecast, by End User
      • 17.3.19.8 Russia Market Size and Forecast, by Stage
      • 17.3.19.9 Russia Market Size and Forecast, by Mode
      • 17.3.19.10 Russia Market Size and Forecast, by Functionality
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Form
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Mode
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Functionality
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Form
    • 17.4.8 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Mode
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Functionality
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Services
      • 17.4.9.4 China Market Size and Forecast, by Technology
      • 17.4.9.5 China Market Size and Forecast, by Application
      • 17.4.9.6 China Market Size and Forecast, by Form
      • 17.4.9.7 China Market Size and Forecast, by End User
      • 17.4.9.8 China Market Size and Forecast, by Stage
      • 17.4.9.9 China Market Size and Forecast, by Mode
      • 17.4.9.10 China Market Size and Forecast, by Functionality
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Services
      • 17.4.10.4 India Market Size and Forecast, by Technology
      • 17.4.10.5 India Market Size and Forecast, by Application
      • 17.4.10.6 India Market Size and Forecast, by Form
      • 17.4.10.7 India Market Size and Forecast, by End User
      • 17.4.10.8 India Market Size and Forecast, by Stage
      • 17.4.10.9 India Market Size and Forecast, by Mode
      • 17.4.10.10 India Market Size and Forecast, by Functionality
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Services
      • 17.4.11.4 Japan Market Size and Forecast, by Technology
      • 17.4.11.5 Japan Market Size and Forecast, by Application
      • 17.4.11.6 Japan Market Size and Forecast, by Form
      • 17.4.11.7 Japan Market Size and Forecast, by End User
      • 17.4.11.8 Japan Market Size and Forecast, by Stage
      • 17.4.11.9 Japan Market Size and Forecast, by Mode
      • 17.4.11.10 Japan Market Size and Forecast, by Functionality
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Services
      • 17.4.12.4 South Korea Market Size and Forecast, by Technology
      • 17.4.12.5 South Korea Market Size and Forecast, by Application
      • 17.4.12.6 South Korea Market Size and Forecast, by Form
      • 17.4.12.7 South Korea Market Size and Forecast, by End User
      • 17.4.12.8 South Korea Market Size and Forecast, by Stage
      • 17.4.12.9 South Korea Market Size and Forecast, by Mode
      • 17.4.12.10 South Korea Market Size and Forecast, by Functionality
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Services
      • 17.4.13.4 Australia Market Size and Forecast, by Technology
      • 17.4.13.5 Australia Market Size and Forecast, by Application
      • 17.4.13.6 Australia Market Size and Forecast, by Form
      • 17.4.13.7 Australia Market Size and Forecast, by End User
      • 17.4.13.8 Australia Market Size and Forecast, by Stage
      • 17.4.13.9 Australia Market Size and Forecast, by Mode
      • 17.4.13.10 Australia Market Size and Forecast, by Functionality
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Services
      • 17.4.14.4 Singapore Market Size and Forecast, by Technology
      • 17.4.14.5 Singapore Market Size and Forecast, by Application
      • 17.4.14.6 Singapore Market Size and Forecast, by Form
      • 17.4.14.7 Singapore Market Size and Forecast, by End User
      • 17.4.14.8 Singapore Market Size and Forecast, by Stage
      • 17.4.14.9 Singapore Market Size and Forecast, by Mode
      • 17.4.14.10 Singapore Market Size and Forecast, by Functionality
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Services
      • 17.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.5 Indonesia Market Size and Forecast, by Application
      • 17.4.15.6 Indonesia Market Size and Forecast, by Form
      • 17.4.15.7 Indonesia Market Size and Forecast, by End User
      • 17.4.15.8 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.9 Indonesia Market Size and Forecast, by Mode
      • 17.4.15.10 Indonesia Market Size and Forecast, by Functionality
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Services
      • 17.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.5 Taiwan Market Size and Forecast, by Application
      • 17.4.16.6 Taiwan Market Size and Forecast, by Form
      • 17.4.16.7 Taiwan Market Size and Forecast, by End User
      • 17.4.16.8 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.9 Taiwan Market Size and Forecast, by Mode
      • 17.4.16.10 Taiwan Market Size and Forecast, by Functionality
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Services
      • 17.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.5 Malaysia Market Size and Forecast, by Application
      • 17.4.17.6 Malaysia Market Size and Forecast, by Form
      • 17.4.17.7 Malaysia Market Size and Forecast, by End User
      • 17.4.17.8 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.9 Malaysia Market Size and Forecast, by Mode
      • 17.4.17.10 Malaysia Market Size and Forecast, by Functionality
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Form
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Mode
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Services
    • 17.5.5 Latin America Market Size and Forecast, by Technology
    • 17.5.6 Latin America Market Size and Forecast, by Application
    • 17.5.7 Latin America Market Size and Forecast, by Form
    • 17.5.8 Latin America Market Size and Forecast, by End User
    • 17.5.9 Latin America Market Size and Forecast, by Stage
    • 17.5.10 Latin America Market Size and Forecast, by Mode
    • 17.5.11 Latin America Market Size and Forecast, by Functionality
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Services
      • 17.5.9.4 Brazil Market Size and Forecast, by Technology
      • 17.5.9.5 Brazil Market Size and Forecast, by Application
      • 17.5.9.6 Brazil Market Size and Forecast, by Form
      • 17.5.9.7 Brazil Market Size and Forecast, by End User
      • 17.5.9.8 Brazil Market Size and Forecast, by Stage
      • 17.5.9.9 Brazil Market Size and Forecast, by Mode
      • 17.5.9.10 Brazil Market Size and Forecast, by Functionality
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Services
      • 17.5.10.4 Mexico Market Size and Forecast, by Technology
      • 17.5.10.5 Mexico Market Size and Forecast, by Application
      • 17.5.10.6 Mexico Market Size and Forecast, by Form
      • 17.5.10.7 Mexico Market Size and Forecast, by End User
      • 17.5.10.8 Mexico Market Size and Forecast, by Stage
      • 17.5.10.9 Mexico Market Size and Forecast, by Mode
      • 17.5.10.10 Mexico Market Size and Forecast, by Functionality
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Services
      • 17.5.11.4 Argentina Market Size and Forecast, by Technology
      • 17.5.11.5 Argentina Market Size and Forecast, by Application
      • 17.5.11.6 Argentina Market Size and Forecast, by Form
      • 17.5.11.7 Argentina Market Size and Forecast, by End User
      • 17.5.11.8 Argentina Market Size and Forecast, by Stage
      • 17.5.11.9 Argentina Market Size and Forecast, by Mode
      • 17.5.11.10 Argentina Market Size and Forecast, by Functionality
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Form
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Mode
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Functionality
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Form
    • 17.6.8 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Mode
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Functionality
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Form
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Mode
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Functionality
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Services
      • 17.6.10.4 UAE Market Size and Forecast, by Technology
      • 17.6.10.5 UAE Market Size and Forecast, by Application
      • 17.6.10.6 UAE Market Size and Forecast, by Form
      • 17.6.10.7 UAE Market Size and Forecast, by End User
      • 17.6.10.8 UAE Market Size and Forecast, by Stage
      • 17.6.10.9 UAE Market Size and Forecast, by Mode
      • 17.6.10.10 UAE Market Size and Forecast, by Functionality
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Services
      • 17.6.11.4 South Africa Market Size and Forecast, by Technology
      • 17.6.11.5 South Africa Market Size and Forecast, by Application
      • 17.6.11.6 South Africa Market Size and Forecast, by Form
      • 17.6.11.7 South Africa Market Size and Forecast, by End User
      • 17.6.11.8 South Africa Market Size and Forecast, by Stage
      • 17.6.11.9 South Africa Market Size and Forecast, by Mode
      • 17.6.11.10 South Africa Market Size and Forecast, by Functionality
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Form
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Mode
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Functionality
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Schneider Electric
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Eaton
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 ABB
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Siemens
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Legrand
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Mitsubishi Electric
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Larsen & Toubro
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Fuji Electric
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 CHINT Group
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Hager Group
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Hyundai Electric
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Toshiba
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Hitachi
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 Hyosung
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 NHP Electrical Engineering Products
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Crompton Greaves
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 NOARK Electric
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Socomec
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Terasaki Electric
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Efacec
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제